| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
9,432 |
8,241 |
$386K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
6,781 |
5,983 |
$181K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
10,652 |
5,651 |
$118K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
6,604 |
5,936 |
$110K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,335 |
1,173 |
$88K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
7,514 |
6,632 |
$71K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,000 |
899 |
$48K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,039 |
1,780 |
$26K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
605 |
598 |
$13K |
| 96127 |
|
1,846 |
1,569 |
$6K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
310 |
263 |
$5K |
| 87807 |
|
580 |
530 |
$4K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
928 |
833 |
$533.49 |
| 81003 |
|
683 |
610 |
$105.30 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
45 |
41 |
$41.78 |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
15 |
13 |
$17.81 |
| 3725F |
|
213 |
184 |
$0.00 |
| 3351F |
|
340 |
284 |
$0.00 |